SCHEMBL27794319

SCHEMBL27794319

CCc1cc(NNC(=O)OCC(Cl)(Cl)Cl)n(-c2cccc(C#N)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K7 O43318 2/20 0.39
▸ NTRK1 P04629 1/20 0.39
▸ NTRK2 Q16620 1/20 0.39
▸ GRM5 P41594 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ROCK2 O75116 1/20 0.33
▸ PDCD1 Q15116 1/20 0.33
▸ CD274 Q9NZQ7 1/20 0.33
▸ NPBWR1 P48145 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ SLC16A3 O15427 1/20 0.33
▸ SLC16A1 P53985 1/20 0.33
▸ MCTS1 Q9ULC4 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2906328 0.91 MAP3K7 (0.42) MAP3K7NTRK1NTRK2GRM5ALDH1A1
SCHEMBL2900071 0.77 HTT (0.39) MAP3K7NTRK1NTRK2GRM5ALDH1A1
SCHEMBL28776251 0.76 SLC16A3 (0.39) ALDH1A1LMNAKDM4ESLC16A3SLC16A1
SCHEMBL2919060 0.75 GRM5 (0.42) MAP3K7NTRK1NTRK2GRM5ALDH1A1
SCHEMBL27722384 0.74 ALDH1A1 (0.39) ALDH1A1LMNAKDM4EHPGDJAK2
SCHEMBL7239764 0.71 NOTUM (0.46) GRM5ALDH1A1ROCK2NOTUM
SCHEMBL27742974 0.70 LMNA (0.38) ALDH1A1LMNANPBWR1KDM4EHPGD
SCHEMBL3777984 0.70 NTRK1 (0.59) NTRK1NTRK2HPGDJAK2MAPK14
SCHEMBL2028690 0.69 ABL1 (0.49) MAP3K7NTRK1NTRK2ALDH1A1LMNA
SCHEMBL2927010 0.68 NSD2 (0.44) GRM5ALDH1A1LMNAROCK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101878031-A The inhibitors of kinases that is used for the treatment of myeloproliferative disease and other proliferative diseases DECIPHERA PHARMACEUTICALS LLC 2010-11-03 — — CN disclosed
Send feedback